Our CEO and founder Erika, and her business partner, Rob, are just two of more than 1.62 billion people worldwide who struggle with anemia, the most common blood disorder.
Their personal battles inspired them to develop affordable and accessible products for regular anemia screening, so people like them could be proactive about their health.
Then-Georgia Tech student Erika Tyburski partners with Dr. Wilbur Lam for a senior design project for instant anemia screening. It’s there she meets Rob Mannino.
In this year, Erika and Rob launch the first AnemoCheck test prototype, win second place at the Georgia Tech Inventure Prize contest, first at the Georgia Tech Ideas to Serve, and secure their first grant.
AnemoCheck is written about in The Journal of Clinical Investigation, and Sanguina officially becomes a company.
The Food and Drug Administration approves first-generation AnemoCheck for clinical use.
AnemoCheck/AnemoCheck Home technology is granted a utility/method patent in the U.S., Europe, and Japan.
Sanguinan secures $2.3 million in seed funding.
In December 2021, AnemoCheck becomes available on Google Play and iOS App Stores in the United States.
In December 2022, the AnemoCheck Premium Subscription launches featuring MyMobile, your unique algorithm with 50% more accurate results.
We’re researchers, designers, doctors, writers, and everyday people who are paving a new path in the healthcare industry to put the power directly in your hands—literally.
Sanguina, Inc.
147 Technology Pkwy, Suite 100, Peachtree Corners, GA 30092
